Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Ebiomedicine|December 3, 2021
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2Yannick Galipeau, Vinayakumar Siragam, Geneviève Laroche, et al.
Frontiers in Public Health|May 24, 2024
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort studyErin Collins, Yannick Galipeau, Corey Arnold, et al.
CMAJ Open|April 13, 2022
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance studyMaala Bhatt, Amy C Plint, Ken Tang, et al.
Frontiers in Immunology|March 4, 2024
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort studyNisha D Almeida, Ian Schiller, Danbing Ke, et al.
Heliyon|September 5, 2022
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimensFrançois Cholette, Rissa Fabia, Angela Harris, et al.
Nature Communications|July 1, 2022
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodiesSun Jin Kim, Zhong Yao, Morgan C Marsh, et al.
BMJ Open|January 23, 2023
Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccinationErin Collins, Yannick Galipeau, Corey Arnold, et al.
CMAJ Open|July 12, 2022
Prevalence of SARS-CoV-2 infection among obstetric patients in Ottawa, Canada: a descriptive studyRomina Fakhraei, Erica Erwin, Kameela M Alibhai, et al.
Plos One|December 7, 2021
Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparisonFrançois Cholette, Christine Mesa, Angela Harris, et al.
Vaccine|March 21, 2026
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD CohortRilwan Azeez, Spencer R Ames, Larisa C Lotoski, et al.
Pageof 4